GSK: Pink Ribbon Red Ribbon

Partnership objectives

Pink Ribbon Red Ribbon (PRRR) is a leading public-private partnership aimed at catalysing the global community to reduce deaths from cervical and breast cancer in sub-Saharan Africa by raising awareness of these diseases and increasing access to quality services to detect and treat them. 

The overarching targets of the partnership are; firstly, to launch an HPV vaccination demonstration programme and achieve at least 80% coverage of girls within the target population. Secondly, the partnership aims to reach at least 80% coverage of screening and treatment for pre-invasive cervical cancer within the appropriate target populations of women. 

What are the health needs and challenges?

There are approximately 19 million women aged 15-44 in Ethiopia. Within this group, the Ethiopian Federal Ministry of Health (FMoH) estimates that there are at least 6,648 new cases of cervical cancer and 3,235 deaths each year resulting from cervical cancer, which ranks as the second-most frequent cancer among women aged 15-44 in the country.

Therefore, in line with the national government’s commitment to address cancer as a key area of focus, Ethiopia has been identified as a key country for PRRR to support, to aid the development of a strategic plan to control the disease. 

Description of partnership activities and how they address needs and challenges

PRRR provides policy support and raises awareness to encourage capacity building and to increase access to services across the continuum of care in Ethiopia. Through the provision of HPV vaccinations, cervical cancer screening and cryotherapy, PRRR is helping to reduce morbidity and mortality from cervical and breast cancer. PRRR also assists in the development of a National Cancer Control Strategy to regionalise cancer treatment. In addition, the partnership performs monitoring and evaluation activities to measure the results of the cervical cancer strategy.

Summary of impact and forward looking information

During 2016, 8,931 women have received screening for cervical cancer, of which, 850 women were VIA positive. This led to the treatment of 779 women with cryotherapy. In addition, PRRR aimed to provide HPV vaccinations for 5,773 women.

In 2017, PRRR will continue to provide training to health workers and supply facilities across Ethiopia to conduct mass screening campaigns and mobile outreaches. It is expected that 11,547 women will receive a HPV vaccination and 24,600 women will be screened for cervical cancer. 

Measurement of progress towards objectives 

Estimated overall value of partnership:

PRRR raised a total of US$7.8 million in contributions, both in cash and in kind, for its programme in Ethiopia, including US$2 million over three years, committed by GSK.

Estimated amount of people impacted:

PRRR aims to provide HPV vaccinations to 11,547 women aged 15-44 and provide cervical cancer screenings to 24,600 women. Of this target group, it is expected that around 1,230 - 2,460 women will be VIA positive, leading to the treatment of 984 -1,968 women with cryotherapy. 

Partnership information

Company(ies) GlaxoSmithKline

Partner(s) Doctors with Africa (CUAAM), Grounds for Health (GfH) Mathiwos Wondu, Ethiopia Cancer Society, Management Sciences for Health (MSH), Pain and Policy Study Group, Pathfinder International

Type of Partner(s) Academia / Hospitals, IGOs, NGOs

Therapeutic Focus Non-Communicable Diseases, Women and Children's Health

Disease(s) Breast Cancer, Cervical Cancer, Children's Health, Women's Health

Program Type(s) Health System Infrastructure - Outreach & Medical Services, Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Ethiopia

Start Date 2015

More information Pink Ribbon Red Ribbon

Anticipated completion date 2018

« Pink Ribbon Red Ribbon continues to grow and thrive as we expand our affiliations, create awareness of the global women’s health landscape, and increase our capacity to serve more women. »

PRRR Board Chair & former US Secretary of State Condoleezza Rice, 9/2016